|
For only the second time, the U.S. government has approved a test in people of a treatment using embryonic stem cells - this time for a rare disease that causes serious vision loss. Advanced Cell Technology, a biotechnology company based in Santa Monica., Calif., said the research should begin early next year, following the green light from the U.S. Food and Drug Administration.
Written by: Malcolm Ritter |
